Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston
boston blog main
boston top stories
clinical trials
3
×
life sciences
national blog main
ally bridge group
big data analytics
biotech ipos
blackrock
cancer
casdin capital
codiak biosciences
cutaneous t-cell lymphoma
diabetic nephropathy
dyne therapeutics
eventide asset management
exosome
fda
focal segmental glomerulosclerosis
goldfinch bio
irving investors
jay ghosh
jazz pharmaceuticals
metacrine
myotonic dystrophy type 1
national top stories
new york blog main
nonalcoholic steatohepatitis
rare disease drugs
rare diseases
salk institute
san diego blog main
san diego top stories
sarepta therapeutics
schroeder adveq
software
third rock ventures
ulcerative colitis
What
ipo
medicines
3
×
million
3
×
brings
company
drug
genetic
new
raised
analysis
based
begin
bio
biosciences
biotech
bio’s
bring
bubbles
cells
class
clinical
codiak
develop
developing
diseases
disorders
dyne
dyne’s
employing
exosome
exosomes
formed
fund
goldfinch
kidney
later
lead
muscle
muscular
preclinical
Language
unset
Current search:
biotech
×
million
×
" clinical trials "
×
medicines
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later